PIC Therapeutics
PrivateLast Round
Series A
Oct 19, 2022
Total Funding Raised
$40M
Company Overview
PIC Therapeutics is a biotechnology company that develops precision-based small molecule therapeutics targeting the pre-initiation complex to inhibit oncogene protein production for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PIC Therapeutics Comparables
Compare PIC Therapeutics with similar companies based on industry and business-model similarity.
PIC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 19, 2022 | ||||
| Seed | Apr 15, 2020 |
Key People
Founding team and executive leadership
PIC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advent Life Sciences | Series A, Seed |
| OrbiMed | Series A |
| Lumira Ventures | Series A |
| Harrington Discovery Institute | Series A |
PIC Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PIC Therapeutics's valuation, stock price, and market status.